Sprint's (S) balance sheet remains concerning to TheStreet's Jim Cramer, even after the company reported that it added subscribers in the latest quarter. But Sprint also reported that its loss widened. Cramer says while he'd speculate in Sprint, he wouldn't want to invest in it.
More from Video
CAG has hung onto the bulk of its recent gains, and could rise to the $50 area, according to the charts and indicators.
Breaking down an approach to the long side of this biotech stock.
AMSC CEO discusses that and China challenges.
One of pharma's biggest CEO's talks M&A action on the exchange.